Literature DB >> 5212380

The mechanism of the inhibition of gastric secretion produced by esophageal ligation in the pylorus-ligated rat.

D A Brodie, P G Knapp.   

Abstract

Esophageal ligation in the pylorus-ligated rat significantly inhibited volume, titratable acidity, and titratable acid output and reduced the incidence of ulcers, perforations, and death of 18-hr pylorus-ligated rats. Draining the saliva outside the body of the rat by esophageal cannulation produced a significant increase in volume and gastric acidity over the esophagus-ligated preparation. A method for collection of saliva in the unanesthetized unstimulated rat was developed, and basal salivary flow was found to be 0.84 ml/4 hr. Administration of 1.0 ml of freshly collected saliva to esophagus + pylorus-ligated rats increased titratable acidity, but not volume of secretion, to the level found in the pylorus-ligated rat. A similar effect was obtained with administration of 1.0 ml of a phosphate buffer. Removal of the salivary glands had no significant effect on gastric acidity in the pylorus-ligated rat and the reduction in volume could be accounted for by the lack of saliva. Gastric secretion in the esophagus + pylorus-ligated rat was stimulated by histamine, carbachol, insulin, and 2-deoxyglucose. When the vagus nerves were cut, stimulation was still obtained with carbachol but not with insulin or 2-deoxyglucose. The data indicated that rat saliva did not contain a specific gastric stimulant material, and esophageal ligation depressed gastric secretion in the pylorus-ligated rat by inhibition of the central vagal activity.

Entities:  

Mesh:

Year:  1966        PMID: 5212380

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  13 in total

1.  Dexamethasone makes the gastric mucosa susceptible to ulceration by inhibiting prostaglandin synthetase and peroxidase--two important gastroprotective enzymes.

Authors:  U Bandyopadhyay; K Biswas; D Bandyopadhyay; C K Ganguly; R K Banerjee
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  Effect of long-term treatment with an anticholinergic drug on gastric secretion in rats.

Authors:  K Kowalewski
Journal:  Am J Dig Dis       Date:  1967-10

3.  Determination of histamine dose causing maximal gastric secretion. Study in rats with gastric fistulas.

Authors:  K Kowalewski; G Chmura
Journal:  Am J Dig Dis       Date:  1968-08

4.  The role of esophageal dysfunction in the pulmonary effects of experimental vagotomy.

Authors:  P S Milley
Journal:  Am J Pathol       Date:  1968-04       Impact factor: 4.307

5.  Gastric acid response to pylorus ligation in rats: is gastrin or histamine involved?

Authors:  J Alumets; M Ekelund; R Håkanson; J Hedenbro; J F Rehfeld; F Sundler; S Vallgren
Journal:  J Physiol       Date:  1982-02       Impact factor: 5.182

6.  Determination of the dose of histamine causing maximal gastric acid secretion in the pylorus-ligated rat.

Authors:  J H Thompson; Y H Lee
Journal:  Am J Dig Dis       Date:  1967-05

7.  The vagus regulates histamine mobilization from rat stomach ECL cells by controlling their sensitivity to gastrin.

Authors:  P Norlén; P Ericsson; M Kitano; M Ekelund; R Håkanson
Journal:  J Physiol       Date:  2005-03-03       Impact factor: 5.182

8.  The gastric antisecretory activity of pyridyl-2-thioacetamide (CMN 131).

Authors:  X B Pascaud; D J Errard; M M Blouin
Journal:  Am J Dig Dis       Date:  1974-06

9.  Bravo capsule system optimizes intragastric pH monitoring over prolonged time: effects of ghrelin on gastric acid and hormone secretion in the rat.

Authors:  Tobias Rudholm; Per-Mikael Hellstrom; Elvar Theodorsson; Colin-Allan Campbell; Peter-Geoffrey McLean; Erik Naslund
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

10.  Mechanisms of gastric acid secretion after pylorus and oesophagus ligation in the rat.

Authors:  R Håkanson; J Hedenbro; G Liedberg; F Sundler; S Vallgren
Journal:  J Physiol       Date:  1980-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.